RxDoctor Payments Data

Ricardo Dancel, MD

Psychiatry · Chelmsford, MANPI 1164520631

Payments from drug & device makers

$8,295in general payments, 2019–2025

Across 442 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alkermes, Inc.$847
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$684
  • Vanda Pharmaceuticals Inc.$679
  • Lundbeck LLC$621
  • Johnson & Johnson$604
  • plus $3K from 10 others

What the payments were for

  • Food & beverage$8,03797%
  • Education$2583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,295 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$49,924
Medicare patients
116
Services billed
642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl73$112,102
Invega SustennaPaliperidone Palmitate31$107,536
Abilify MaintenaAripiprazole23$59,779
RexultiBrexpiprazole27$37,339
Aripiprazole168$31,695
Lurasidone Hcl33$16,205
TrintellixVortioxetine Hydrobromide15$11,981
Clozapine106$6,410
Paliperidone ErPaliperidone25$6,343
AzstarysSerdexmethylphen/Dexmethylphen13$5,336
Bupropion XlBupropion Hcl205$4,133
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine189$4,052
Quetiapine Fumarate225$3,648
Trazodone Hcl345$3,186
Guanfacine Hcl ErGuanfacine Hcl22$2,633

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,843$112,10273 claims
Johnson & JohnsonInvega Sustenna$604$107,53631 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$520$97,11950 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$426$11,98115 claims
Corium, LLCAzstarys$595$5,33613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →